Bioniche Pharma and Synerx Pharma, have launch of Fomepizole Injection, which is the generic equivalent of Paladin Labs’ Antizol.
George Zorich, president for US Operations at Bioniche Pharma, said: “The addition of Fomepizole to Bioniche’s product offering further broadens our base of niche injectables.”
Reportedly, Bioniche Pharma and Synerx Pharma entered into a definitive agreement, under which Bioniche Pharma has the rights to market and distribute Fomepizole in the US.
Bioniche will supply Fomepizole Injection in 1.5g /1.5ml vials.
Bioniche Pharma is a manufacturer of injectable pharmaceutical products serving a variety of niche markets, with expertise in injectable hyaluronic acid products for use in orthopedics, rheumatology, urology and dermatology.